Cardiol Therapeutics (CRDL) Shares Issued (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Shares Issued came in at -$163.3 million in Q1 2026, down 24.91% YoY from -$217.4 million in Q1 2025, and down 206.85% on a QoQ basis from $152.8 million in Q4 2025.
Cardiol Therapeutics (CRDL) Shares Issued (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Shares Issued data on file, last reported at -$163.3 million in Q1 2026.
- Quarterly Shares Issued fell 24.91% year-over-year to -$163.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$163.3 million (down 24.91% YoY) and the FY2025 annual result came in at $152.8 million, up 19.02% from the prior year.
- Shares Issued eased to -$163.3 million in Q1 2026, from $152.8 million in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $152.8 million in Q4 2025 to a low of -$163.3 million in Q1 2026.
- A 5-year average of $52.4 million and a median of $111.2 million in 2023 frame the typical range for Shares Issued.
- Annual changes were most pronounced in 2022 — Shares Issued jumped 110.97% — and 2025, when it tumbled 218.87%.
- Tracing CRDL's Shares Issued over 5 years: stood at $108.7 million in 2022, then climbed by 0.36% to $109.1 million in 2023, then gained by 17.68% to $128.4 million in 2024, then climbed by 19.02% to $152.8 million in 2025, then slumped by 206.85% to -$163.3 million in 2026.
- The last three Shares Issued figures came in at -$163.3 million (Q1 2026), $152.8 million (Q4 2025), and -$149.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cardiol Therapeutics | 215.50 Mn | 196.65 Mn | - | 166.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -163.26 Mn |
| Mar 31, 2026 | -163.26 Mn |
| Dec 31, 2025 | 152.79 Mn |
| Dec 31, 2025 | 152.79 Mn |
| Sep 30, 2025 | -149.62 Mn |
| Sep 30, 2025 | -149.62 Mn |
| Mar 31, 2025 | -130.70 Mn |
| Mar 31, 2025 | -130.70 Mn |
| Dec 31, 2024 | 128.38 Mn |
| Dec 31, 2024 | 128.38 Mn |
| Sep 30, 2024 | 125.86 Mn |
| Sep 30, 2024 | 125.86 Mn |
| Dec 31, 2023 | 109.09 Mn |
| Dec 31, 2023 | 109.09 Mn |
| Sep 30, 2023 | 110.23 Mn |
| Sep 30, 2023 | 110.23 Mn |
| Dec 31, 2022 | 108.70 Mn |
| Dec 31, 2022 | 108.70 Mn |
| Sep 30, 2022 | 112.66 Mn |
| Sep 30, 2022 | 112.66 Mn |